Evidence map›Paper›PMID 37009507›Full record

ArticleFrontiers in cellular and infection microbiology2023

Construction and application of a heterogeneous quality control library for the Xpert MTB/RIF assay in tuberculosis diagnosis.

Zehao Guan, Xuefei Han, Weigang Huang, Xueliang Wang, Hualiang Wang, Yun Fan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zehao GuanR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Xuefei HanR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Weigang HuangR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Xueliang WangR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Hualiang WangR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Yun FanR&D Laboratory of Quality Control Material, Shanghai Center for Clinical Laboratory, Shanghai, China.
Shanghai Clinical Research Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proficiency testing based on quality control materials is an important component of the quality assurance system for detection methods. However, in the detection of infectious diseases, it is a challenge to use quality control materials derived from clinical samples or pathogens owing to their infectious nature. The Xpert MTB/RIF assay, endorsed by the World Health Organization, is one of the most widely implemented assays in the detection of

Indexed as

Mycobacterium tuberculosisTuberculosisChinaDrug Resistance, BacterialHumansQuality ControlRifampinSensitivity and SpecificityRifampinheterogeneous hostMycobacterium tuberculosisproficiency testingquality control materialXpert MTB/RIF assay

Identifiers

PMID37009507
PMCPMC10063913
OpenAlexW4327715478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.